A single next generation sequencing assay for detection of driver mutations, rearrangements and copy number abnormalities in plasma cell dyscrasias - Poll - MDSpire

A single next generation sequencing assay for detection of driver mutations, rearrangements and copy number abnormalities in plasma cell dyscrasias

  • By

  • Cecilia Bonolo de Campos

  • Daniela Trujillo

  • James Smadbeck

  • Mariano Arribas

  • Hongwei Tang

  • Neeraj Sharma

  • Gregory J. Ahmann

  • Shaji K. Kumar

  • A. Keith Stewart

  • Rafael Fonseca

  • P. Leif Bergsagel

  • Yan W. Asmann

  • Linda B. Baughn

  • Esteban Braggio

  • March 28, 2026

  • 0 min

Share

Original Source(s)

A single next generation sequencing assay for detection of driver mutations, rearrangements and copy number abnormalities in plasma cell dyscrasias

  • by Cecilia Bonolo de Campos, Daniela Trujillo, James Smadbeck, Mariano Arribas, Hongwei Tang, Neeraj Sharma, Gregory J. Ahmann, Shaji K. Kumar, A. Keith Stewart, Rafael Fonseca, P. Leif Bergsagel, Yan W. Asmann, Linda B. Baughn, Esteban Braggio

  • March 28, 2026

Related Content

Patient-reported outcomes after idecabtagene vicleucel vs. ciltacabtagene autoleucel CAR-T for multiple myeloma

Targeting CD38 Enzymatic Function in Antibody-Driven Immunotherapy for Multiple Myeloma: Insights from Basic Research

Clinical Reasoning in Practice: Implementing High-Value Care When Data Discrepancies Arise